Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) Appoints Janice M. Smiell, M.D. As its First Chief Medical Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LANGHORNE, Pa.--(BUSINESS WIRE)--Alliqua, Inc. (NASDAQ:ALQA) (“Alliqua” or “the Company”) has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created position. Dr. Smiell has more than two decades of experience in clinical trial design, clinical development and planning, and clinical regulatory submissions. In practice as a general surgeon, she has specialized in wound healing, wound care and trauma. Most recently, she was an independent consultant in drug, device, tissue and cells clinical development planning, as well as medical monitoring and management.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC